Lymphocyte deficiencies increase susceptibility to friend virus-induced erythroleukemia in Fv-2 genetically resistant mice

被引:44
作者
Hasenkrug, KJ [1 ]
机构
[1] NIAID, Rocky Mt Labs, Persistent Viral Dis Lab, NIH, Hamilton, MT 59840 USA
关键词
D O I
10.1128/JVI.73.8.6468-6473.1999
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The study of genetic resistance to retroviral diseases provides insights into the mechanisms by which organisms overcome potentially lethal infections. Fv-2 resistance to Friend virus-induced erythroleukemia acts through noninmunological mechanisms to prevent early virus spread, but it does not completely block infection. The current experiments were done to determine whether Fv-2 alone could provide resistance or whether immunological mechanisms mere also required to bring infection under control. Fv-2-resistant mice that were CD4(+) T-cell deficient were able to restrict early virus replication and spread as well as normal Fv-2-resistant mice, but they could not maintain control and developed severe Friend virus-induced splenomegaly and erythroleukemia by 6 to 8 weeks postinfection, Mice deficient in CD8(+) T cells and, to a lesser extent, B cells were also susceptible to late Friend virus-induced disease. Thus, Fv-2 resistance does not independently prevent FV-induced erythroleukemia but works in concert with the immune system by limiting early infection long enough to allow virus-specific immunity time to develop and facilitate recovery.
引用
收藏
页码:6468 / 6473
页数:6
相关论文
共 54 条
[1]   CELLULAR SITE AND MODE OF FV-2 GENE-ACTION [J].
BEHRINGER, RR ;
DEWEY, MJ .
CELL, 1985, 40 (02) :441-447
[2]   FRIEND VIRUS-INDUCED ERYTHROLEUKEMIA AND THE MULTISTAGE NATURE OF CANCER [J].
BENDAVID, Y ;
BERNSTEIN, A .
CELL, 1991, 66 (05) :831-834
[3]  
BRITT WJ, 1983, J IMMUNOL, V130, P2363
[5]  
CHESEBRO B, 1978, J IMMUNOL, V120, P1081
[6]  
CHESEBRO B, 1990, ANNU REV IMMUNOL, V8, P477, DOI 10.1146/annurev.iy.08.040190.002401
[7]   THERAPY WITH MONOCLONAL-ANTIBODIES BY ELIMINATION OF T-CELL SUBSETS INVIVO [J].
COBBOLD, SP ;
JAYASURIYA, A ;
NASH, A ;
PROSPERO, TD ;
WALDMANN, H .
NATURE, 1984, 312 (5994) :548-551
[8]  
CORBIN A, 1993, J VIROL, V65, P2539
[9]   Characterization of a live-attenuated retroviral vaccine demonstrates protection via immune mechanisms [J].
Dittmer, U ;
Brooks, DM ;
Hasenkrug, KJ .
JOURNAL OF VIROLOGY, 1998, 72 (08) :6554-6558
[10]  
DOIG D, 1979, J EXP MED, V150, P10, DOI 10.1084/jem.150.1.10